A carregar...
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration and is the most common cause of dementia. Immunotherapy has recently been regarded as a potential treatment for AD. This stems from the fact that the clinical and pathological findings from the active AD vaccine trial suggest...
Na minha lista:
| Publicado no: | Immunotargets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918245/ https://ncbi.nlm.nih.gov/pubmed/27471709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S49923 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|